Psychic disturbances associated with sodium valproate plus levetiracetam [2]

Annals of Pharmacotherapy

Volumn 41, Issue 3, 2007, Pages 527-528

  Siniscalchi, Antonio ^a   Gallelli, Luca ^b   De Fazio, Salvatore ^b   De Sarro, Giovambattista ^b  

^a ANNUNZIATA HOSPITAL   (Italy)

^b UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; ETIRACETAM; VALPROIC ACID;

ADULT; AGITATION; ANXIETY; BEHAVIOR; CASE REPORT; COMPLEX PARTIAL SEIZURE; DISEASE COURSE; DRUG BLOOD LEVEL; DRUG DOSE INCREASE; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENTIATION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; HUMAN; INSOMNIA; LETTER; MENTAL DISEASE; PRIORITY JOURNAL; PSYCHOSIS; SIDE EFFECT; TREATMENT RESPONSE;

ANTICONVULSANTS; ANXIETY; DRUG THERAPY, COMBINATION; EPILEPSIES, PARTIAL; FEMALE; HUMANS; MIDDLE AGED; PIRACETAM; PSYCHOMOTOR AGITATION; SLEEP INITIATION AND MAINTENANCE DISORDERS; VALPROIC ACID;

EID: 34047192366     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1H614     Document Type: Letter

References (5)

1. Willmore LJ, Whelless JW, Pellok JM. Adverse effects of antiepileptic drugs. In: Pellok JM, Dodson WE, Bourgeois BF. Pediatric epilepsy: diagnosis and therapy. 2nd ed, New York: Demos, 2001:343-55.
2. Wolf P, Inoue V, Boder-Wanner U. Psychiatric complications of absence therapy and their relation to alteration of sleep. Epilepsia 1984;25:556-9.
3. Kossoff EH, Bergey GK, Freeman JM, Vining EPG. Levetiracetam psychosis in children with epilepsy. Epilepsia 2001;42:1611-3.
4. Youroukos S, Lazopoulou D, Michelakou D, Karagianni J. Acute psychosis associated with levetiracetam. Epileptic Disord 2003;5:117-9.
5. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-45.